Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
J Surg Oncol. 2012 Oct 1;106(5):586-94. doi: 10.1002/jso.23112. Epub 2012 Apr 3.
Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Due to its rarity, heterogeneity, and a lack of a comprehensive understanding of the pathogenesis, little progress has been made in treatment and outcomes. The current review explores the past, present, and future of the understanding and treatment of this disease process.
肾上腺皮质癌(adrenocortical carcinoma,ACC)是一种罕见的内分泌恶性肿瘤。由于其罕见性、异质性以及对发病机制缺乏全面了解,在治疗和预后方面进展甚微。本综述探讨了对这种疾病过程的认识和治疗的过去、现在和未来。